(qlmbusinessnews.com . Thu 11th Dec, 2025) London, UK —
Dame Emma Walmsley Pledges Unprecedented GSK Expansion in US by 2030
Dame Emma Walmsley, the Chief Executive of British pharmaceutical titan GSK, has declared the United States as the prime destination for business investment. Leading GSK, a powerhouse in the production of vaccines and medicines, Dame Emma announced a colossal investment plan of $30bn (£23bn) in the US by the end of 2030, painting a picture of a bright future for the company across the Atlantic.
This announcement emerges amidst a backdrop of notable pharmaceutical enterprises retreating their investment plans from the UK, citing prolonged dissatisfaction with NHS medication funding and influences from former US President Donald Trump urging production shifts to the US. In contrast, Dame Emma, who is set to step down from her role at GSK in January after an eight-year tenure, embraced a recent agreement ensuring the NHS compensates to secure zero tariffs on UK pharmaceutical exports to the US.
Addressing the press at GSK's headquarters in central London, Dame Emma expressed staunch support for the company's commitments in the US, which is responsible for over half of its revenue. She highlighted the US's unrivaled position in drug and vaccine innovation launches, lauding it alongside China as the top global markets for business development within the pharmaceutical sector.
GSK's decision to enhance its presence in the US comes in the wake of American pharmaceutical firm Merck (known as MSD in Europe) halting a £1bn expansion in the UK, and AstraZeneca pausing a £200m investment in a Cambridge research centre, opting instead to funnel resources into the US market.
The recent narrative has seen several drug companies expressing tepidity towards UK investment, challenging the government's portrayal of the nation as a leading force in life sciences. Despite these hurdles, Dame Emma views the tariff-elimination deal on drug exports to the US as a forward stride for the UK, suggesting a positive shift against a backdrop of dwindling NHS medicine spending relative to other nations' healthcare budgets.
This agreement, by increasing NHS spending on medicines in exchange for a three-year guarantee of no US import taxes on British-made pharmaceuticals, heralds a potential boost for innovation. Dame Emma underscored this with the example of GSK's innovative asthma treatment, soon expected to receive NHS approval, which promises a significant reduction in hospital admissions for severe asthma patients.
Addressing broader health issues, Dame Emma remarked on the UK's health discrepancies tied to socio-economic factors, underscoring a pressing need for nutritional education and diet improvements. Drawing from her personal experiences with childbirth and healthcare in London, Paris, and New York, she noted stark contrasts in healthcare delivery and support between the NHS and US systems, advocating for a better balance of cost, access, and outcomes within the NHS.
Additionally, Dame Emma, who holds a position on the board of Microsoft, touched upon the transformative potential of AI in healthcare, envisioning a future where innovation sees a marked increase in success rates, significantly impacting health outcomes globally. She concluded with a universal truth on the importance of health, positioning it as a paramount concern shared across humanity.
This News Story is brought to you by QLM Business News, your Digital Media Channel.
Visit QLM businessnews.com for more business news stories. Also follow us on Facebook, X, and Youtube.
To help QLM Business News bring you more news stories like this, please like, share, and subscribe.
Unlock unparalleled business growth and effortlessly attract a stream of new customers through QLM Business News Sponsored Advertising. Elevate your brand's presence and captivate your target audience with precision. Visit QLMbusinessnews.com and click on “Advertise” to harness the power of strategic advertising. Don't miss this unparalleled opportunity to propel your business to new heights of success!
Disclaimer: All images presented herein are intended solely for illustrative purposes and may not accurately depict the true likeness of the subjects, objects, or individuals referenced in the accompanying news stories.
